Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2013; 19(32): 5286-5294
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5286
Table 7 Comparison KRAS somatic mutations as a function of tumoral parameters
Presence of KRAS mutations (n = 16)Absence of KRAS mutation (n = 35)P
MSI25.00%17.10%NS
MMR expression loss25.00%17.10%NS
TP53 mutations46.70%65.60%NS
TP53 overexpression31.30%45.70%NS
MUC5AC overexpression25.00%31.40%NS